Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort
- 280 Downloads
Retention in Methadone Maintenance Treatment (MMT) is superior to that of other therapies for opioid addiction, but with international retention rates around 50 % after 1 year of treatment, there remains a need for improved retention rates.
This study aimed to explore the demographic and clinical factors predicting retention in MMT.
Face-to-face surveys with MMT patients in a Dublin methadone clinic were conducted. Retention was assessed by the presence and duration of breaks in treatment at any stage.
189 patients participated in the study. 46 % (n = 87) reported having at least one break in treatment, and the median duration of a break was 3 months. Age, current methadone dose and prescription of antipsychotic medication were significant predictors of retention. Patients who were older, single, living in their own home, on a higher dose of methadone, or taking antipsychotic medications had fewer breaks in treatment. Males tended to have significantly longer breaks. Patients reported that the main reasons for breaks were relapse into drug use (21.8 %, n = 19), incarceration (11.4 %, n = 10), weary of MMT (13.7 %, n = 12) or problems at the clinic (10.3 %, n = 9). Factors enabling regular attendance included wanting to get or stay clean (37.5 %, n = 51), avoidance of withdrawal symptoms (16.1 %, n = 22), methadone dependence (13.9 %, n = 19) and services provided (10.2 %, n = 14).
Patients who were older, single, living in their own home, on a higher dose of methadone, or taking antipsychotic medications had fewer breaks in treatment.
KeywordsMethadone maintenance therapy Retention Demographic factors Clinical factors
We thank the patients involved in this research.
Conflict of interest
None to declare.
The current study has been approved by the Drug Treatment Centre Board Ethics Committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of the Helsinki and its later amendments.
- 1.Addiction. EUEMCfDaD (2011) Annual report 2011: the state of the drug problems in Europe. EMCDDA, LuxembourgGoogle Scholar
- 2.Cox G, Comiskey C, Kelly P (2007) ROSIE findings 4: summary of 1-year outcomes: methadone modality. National Advisory Committee on Drugs, DublinGoogle Scholar
- 3.Board DTC (2012) Annual report 2011. Drug Treatment Centre Board, DublinGoogle Scholar
- 4.Farrell M, Barry J (2009) The introduction of the national opioid treatment protocol. HSE, DublinGoogle Scholar
- 5.Bellerose D, Carew AM, Lyons S (2011) Trends in treated problem drug use in Ireland 2005–2010. Health Research Board, DublinGoogle Scholar
- 8.Chekuria V, Gerberb D, Brodiec A, Krishnadasd R (2012) Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addict Behav 37(1):2Google Scholar
- 11.Addiction. NCPoEMToO (1998) Effective medical treatment of opiate addiction. JAMA 280(22):7Google Scholar
- 12.Zhang L, Chow EPF, Zhuang X, Liang Y, Wang Y, Tang C, Ling L, Tucker JD, Wilson DP (2013) Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis. PloS one 8(7):e68906 (1932–6203 (Electronic)) CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Gossop M, Marsden J, Stewart D (2001) NTORS after five years the national treatment outcome research study: changes in substance use, health and criminal behaviour during the five years after intake. Crown Copyright, LondonGoogle Scholar
- 18.Cosusins G, Teljeur C, Motterlini N, McCowan C, Dimitrov BD, Fahey T (2011) Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. J Subst Abus Treat 41(3):8Google Scholar
- 20.National Institute of Drug Abuse (2007) National institute on drug abuse international programme. National Institute on Drug Abuse, BethesdaGoogle Scholar
- 24.Zhou K, Zhuang G, Zhuang G. Retention in methadone maintenance treatment in mainland China, 2004–2012: a literature review. doi: 10.1016/j.addbeh.2013.09.001 (1873-6327(Electronic))
- 26.Peles E, Schreiber S, Adelson M (2010) 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 107(2–3):7Google Scholar
- 29.Faggiano F, Vigna-Taglianti F, Versino E, Lemma P (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 3:1–47Google Scholar
- 32.Hser Y, Anglin M, Liu Y (1990–1991) A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment (MMT) center in Israel. Int J Addict 25(11a):20Google Scholar
- 35.Feinberg D, Hartman N (1991) Methadone and schizophrenia. Am J Psychiatry 148(12):2Google Scholar
- 36.Fareed A, Vayalapalli S, Stout S, Casarella J, Drexler K, Bailey S (2011) Effect of methadone maintenance treatment on heroin craving, a literature review. J Addict Dis 30(1):11Google Scholar
- 38.Grüsser S, Mörsen C, Wölfling K, Flor H (2007) The relationship of stress, coping, effect expectancies and craving. Eur Addict Res 13(1):7Google Scholar
- 39.Rang H, Dale M (2011) Rang and Dale’s pharmacology, 7th edn. Saunders Elsevier, St. LouisGoogle Scholar